Position in PHAT
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$857,014
New position
Shares Held
77,139
first reported quarter
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026KBC Group NV holds $172,610,851 across 111 Biotechnology names. PHAT ranks #18 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,208 | $56,803,459 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,473 | $29,725,778 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
102,199 | $19,320,720 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,501,931 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,185,189 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,524 | $6,790,774 | |
| 7 | INSM |
INSMED Inc
|
37,347 | $6,106,981 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $5,558,411 |
All Filings in PHAT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $857,014 | 77,139 | Shares | Defined | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||